Growing body of ORLADEYO ® clinical data and real-world evidence demonstrates consistent reductions in HAE attack burden and healthcare utilization across diverse patient populations — New post hoc ...
Neoadjuvant HPV16-specific arenavirus-based immunotherapy HB-200 plus chemotherapy followed by response-stratified de-intensification in HPV16+ oropharyngeal cancer: TARGET-HPV. This is an ASCO ...
MedPage Today on MSN
CRISPR Gene Therapy Slashes Hereditary Angioedema Attacks
Phase III trial shows majority of patients become attack-free without ongoing meds ...
(RTTNews) - KalVista Pharmaceuticals, Inc. (KALV) announced Monday that it has terminated the KOMPLETE phase 2 clinical trial for KVD824 for the prevention of attacks in people with hereditary ...
Efficacy and Safety of BL-B01D1 in Patients With Locally Advanced or Metastatic Urothelial Carcinoma: A Phase II Clinical Trial This randomized phase II/III trial enrolled patients with SCLC, no brain ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results